Reducing uncertainty in risk assessment by using specific knowledge to replace default options

Drug Metabolism Reviews

Volumn 28, Issue 1-2, 1996, Pages 149-179

  Mcclellan, Roger O ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CANCER RISK; CARCINOGENICITY; CONFERENCE PAPER; HUMAN; INTOXICATION; NONHUMAN; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 0029938539     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539608993997     Document Type: Conference Paper

References (64)

1. Andersen, M. E. (1991). Quantitative risk assessment and chemical carcinogens in occupational environments, Appl. Ind. Hyg., 3, 267-273.
2. Andersen, M. E., H. J. Clewell III, M. L. Gargas, M. G. MacNaughton, R. H. Reitz, R. J. Nolan, and M. J. McKenna. (1991). Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans, Toxicol. Appl. Pharmacol., 108, 14-27.
3. Andersen, M. E., H. J. Clewell III, M. L. Gargas, F. A. Smith, and R. H. Reitz. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicol. Appl. Pharmacol., 87, 185-205.
4. Andersen, M. E., K. Krishnan, R. B. Conolly, and R. O. McClellan. (1992). Biologically based modeling in toxicology research, in Medical Toxicology (Archives of Toxicology Suppl. 15) (H. M. Bolt, F. A. de Wolff, and P. Th. Henderson, eds.), Springer-Verlag, Berlin, pp. 217-227.
5. Andjelkovich, D. A., D. B. Janszen, M. H. Brown, R. B. Richardson, and F. J. Miller. (1995). Mortality of iron foundry workers. IV. The association of formaldehyde exposure with malignant and nonmalignant disease, J. Occup. Environ. Med., 37(7), in press.
6. Bond, J. A., L. Recio, and D. Andjelkovich. (1995). Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace, Carcinogenesis, 16, 165-171.
7. 2u-Globulin-mediated male rat nephropathy and kidney cancer: Relevance to human risk assessment, CIIT Activities, 13(4), 1-8 (Chemical Industry Institute of Toxicology, Research Triangle Park, NC).
8. Borghoff, S. J., and W. H. Lagarde. (1993). Assessment of binding of 2,2,4-trimethyl-2-pentanol to low molecular weight proteins isolated from kidneys of male rats and humans, Toxicol. Appl. Pharmacol., 119, 228-235.
9. 2u-globulin) nephropathy in renal carcinogenesis," Regulat. Toxicol. Pharmacol., 18, 357-364.
10. 2u-globulin nephropathy, Ann. Rev. Pharmacol. Toxicol., 30, 349-367.
11. Butterworth, B. E., and S. R. Eldridge. (1992). A decision tree approach for carcinogen risk assessment: Applications to 1,4-dichlorobenzene, CIIT Activities, 12, 1-11.
12. Butterworth, B. E., and S. R. Eldridge. (1995). A decision tree approach for carcinogen risk assessment, in Growth Factors and Tumor Promotion (M. McClain and B. E. Butterworth, eds.), Progress in Clinical and Biological Research, Wiley-Liss (in press).
13. Butterworth, B. E., J. L. Larson, R. B. Conolly, S. J. Borghoff, G. L. Kedderis, and D. C. Wolf. (1994). Risk assessment issues associated with chloroform-induced mouse liver tumors, CIIT Activities, 14, 1-7.
14. Butterworth, B. E., J. A. Popp, R. B. Conolly, and T. L. Goldsworthy. (1992). Chemically-induced cell proliferation in carcinogenesis, in Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, and A. J., McMichael, eds.), IARC Scientific Publ. 116, pp. 279-305.
15. Casanova, M., D. F. Deyo, and H. d'A Heck. (1989). Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer-344 rats: Analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation, Fundam. Appl. Toxicol., 12, 397-417.
16. Casanova, M., K. T. Morgan, E. A. Gross, O. R. Moss, and H. d'A. Heck. (1994). DNA-protein cross-links and cell replication at specific sites in the nose of F-344 rats exposed subchronically to formaldehyde, Fundam. Appl. Toxicol., 23, 525-536.
17. Casanova, M., K. T. Morgan, W. H. Steinhagen, J. I. Everitt, J. A. Popp, and H. d'A. Heck. (1991). Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: Pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man, Fundam. Appl. Toxicol., 77, 409-428.
18. Cochrane, J. E., and T. R. Skopek. (1994). Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts, Carcinogenesis, 15, 713-717.
19. Conolly, R. B., and M. E. Andersen. (1993). An approach to mechanism-based cancer-risk assessment for formaldehyde, Environ. Health Perspect. Supplements, 101(Suppl. 6), 169-176
20. Conolly, R. B., K. T. Morgan, M. E. Andersen, T. M. Monticello, and H. J. Clewell III. (1992). A biologically-based risk assessment strategy for inhaled formaldehyde, Comments Toxicol., 4, 269-288
21. Crump, K. S., and R. B. Howe. (1984). The multistage model with a time-dependent dose pattern: Applications to carcinogenic risk assessment, Risk Anal., 4, 163-176 (1984).
22. Environmental Protection Agency (EPA). (1985). Health assessment document for chloroform, EPA/600/8-84/004F.
23. Environmental Protection Agency (EPA). (1986). Guidelines for carcinogen risk assessment, Fed. Regist., 51, 33992-34003.
24. Environmental Protection Agency (EPA). (1987). Assessment of health risks to garment workers and certain home residents from exposure to formaldehyde, U.S. Environmental Protection Agency, Office of Pesticides and Toxic Substances, Washington, DC.
25. Environmental Protection Agency (EPA). (1991a). Alpha 2u-globulin: Association with chemically induced renal toxicity and neoplasia in the male rat (EPA/625/3-91/019F), U.S. Environmental Protection Agency, Washington, DC.
26. Environmental Protection Agency (EPA). (1991b). Formaldehyde risk assessment update, U.S. Environmental Protection Agency, Office of Pesticides and Toxic Substances, Washington, DC.
27. Environmental Protection Agency (EPA). (1994a). Integrated risk Information System (IRIS) Database, May 3.
28. Environmental Protection Agency (EPA). (1994b). Working paper for considering draft revisions to the U.S. EPA guidelines for cancer risk assessment, Appendix D, in Science and Judgment in Risk Assessment, National Research Council, Committee on Risk Assessment of Hazardous Air Pollutants, National Academy Press, Washington, DC, pp. 383-447.
29. 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats, Environ. Health Perspect., 99, 313-349
30. Heck, H. d'A., M. Casanova, and T. B. Starr. (1990). Formaldehyde toxicity - new understanding, Crit. Rev. Toxicol., 20, 397-426
31. Himmelstein, M. W., B. Asgharian, M. J. Turner, M. A. Medinsky, and J. A. Bond. (1994). Interspecies differences in 1,3-butadiene metabolism, CIIT Activities, 1-9 (1994)
32. International Agency for Research on Cancer (IARC). (1992). Occupational Exposures to Mists and Vapors from Strong Inorganic Acids; and Other Industrial Chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 54, pp. 237-285, IARC, Lyon, France.
33. International Agency for Research on Cancer (IARC). (1994). Some Industrial Chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60, IARC, Lyon, France.
34. International Agency for Research on Cancer (IARC). (1995). Occupational Exposures to Wood Dusts and Formaldehyde, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 62, IARC, Lyon, France.
35. International Program on Chemical Safety (IPCS). (1995). Environmental Health Criteria 163: Chloroform, World Health Organization, Geneva.
36. Jorgenson, T. A., E. F. Meierhenry, C. J. Rushbrook, R. J. Bull, and M. Robinson. (1985). Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice, Fundam. Appl. Toxicol., 5, 760-769.
37. Kerns, W. D., K. L. Pavkov, D. J. Donofrio, E. J. Gralla, and J. A. Swenberg. (1983). Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure, Cancer Res., 43, 4382-4392.
38. Kimbell, J. S., and K. T. Morgan. (1990). Upper respiratory tract toxicology, airflow modeling, and supercomputers, CIIT Activities, 10, 1-9.
39. Larson, J. L., C. S. Sprankle, and B. E. Butterworth, (1994a). Lack of chloroform-induced DNA repair in vitro and in vivo in hepatocytes of female B6C3F1 mice, Environ. Mol. Mutagen., 23, 132-136.
40. 1 mice: Comparison of administration by gavage in corn oil vs. ad libitum in drinking water, Fundam. Appl. Toxicol., 22, 90-102.
41. MacFarland, H. N., C. E. Ulrich, C. E. Holdsworth, D. N. Kitchen, W. H. Halliwell, and S. C. Blum. (1984). A chronic inhalation study with unleaded gasoline vapor, J. Am. Coll. Toxicol., 3, 231-248.
42. McClellan, R. O. (1995). An introduction to inhalation toxicology, in Concepts in Inhalation Toxicology (R. O. McClellan and R. O. Henderson, eds.), 2nd ed., Taylor & Francis, Washington, DC.
43. McClellan, R. O., and W. North. (1994). Making full use of scientific information in risk assessment, in Science and Judgment in Risk Assessment, National Academy Press, Washington, DC, Appendix N-2-1 to 11.
44. McLaughlin, J. K. (1994). Formaldehyde and cancer: A critical review, Int. Arch Occup. Environ. Health, 66, 295-301.
45. 2u-globulin) nephropathy) in renal carcinogenesis, Regulat. Toxicol. Pharmacol., 16, 111-125.
46. 2u-globulin and renal carcinogenesis, Regul. Toxicol. Pharmacol., 18, 365-368.
47. Melnick, R. L. (1995). Mechanistic data indicate that 1,3-butadiene is a human carcinogen, Carcinogenesis, 16, 157-163.
48. Melnick, R. L., J. Huff, B. J. Chou, and R. A. Miller. (1990). Carcinogenicity of 1,3-butadiene in B6C3F1 mice at low exposure concentrations, Cancer Res., 50, 6592-6599.
49. Monticello, T. M., F. J. Miller, and K. T. Morgan. (1991). Regional increases in rat nasal respiratory epithelial cell proliferation following acute and subacute inhalation of formaldehyde, Toxicol. Appl. Pharmacol., 111, 409-421.
50. Moolgavkar, S. H. (1988). Biologically motivated two-stage model for cancer risk assessment, Toxicol. Lett., 43, 139-150.
51. Moolgavkar, S. H., A. Dewanji, and D. J. Venzon. (1988). A stochastic two-stage model for cancer risk assessment. 1. The hazard function and the probability of tumors, Risk Anal., 8, 383-392.
52. Moolgavkar, S. H., and A. G. Knudson. (1981). Mutation and cancer: A model for human carcinogenesis, J. Natl. Cancer Inst., 66, 1037-1052.
53. Moolgavkar, S. H., and D. J. Venzon. (1979). Two event models for carcinogenesis: Incidence curves for childhood and adult tumors, Math Biosci., 47, 55-77.
54. Morgan, K. T., J. S. Kimbell, T. M. Monticello, A. L. Patra, and A. Fleischman. (1991). Studies of inspiratory airflow patterns in the nasal passages of the F344 rat and rhesus monkey using nasal molds: Relevance to formaldehyde toxicity, Toxicol. Appl. Pharmacol., 110, 223-240.
55. National Cancer Institute (NCI). (1976). Carcinogenesis Bioassay of Chloroform, Bethesda, MD, National Tech. Inform. Service No. PB264018/ AS.
56. National Research Council (NRC). (1983). Risk Assessment in the Federal Government: Managing the Process, Washington, DC, National Academy Press.
57. National Research Council (NRC). (1994). Science and Judgment in Risk Assessment, Washington, DC, National Academy Press.
58. National Toxicology Program (NTP). (1988). Carcinogenesis studies of dlimonene in F-344/N rats and B6C3F1 mice, NTP Technical Rep. 347, National Toxicology Program, Research Triangle Park, NC.
59. Owen, P. E., J. R. Glaister, I. F. Gaunt, and D. H. Pullinger. (1987). Inhalation toxicity studies with 1,3-butadiene. III. Two year toxicity/ carcinogenicity studies in rats, Am. Ind. Hyg. Assoc. J., 48, 407-413.
60. Putnam, S. W., and J. D. Graham. (1993). Formaldehyde science: From the laboratory to the regulatory arena, in Keeping Pace with Science and Engineering: Case Studies in Environmental Regulation (M. F. Uman, ed.), National Academy Press, Washington, DC, pp. 189-220.
61. Recio, L., S. Sisk, L. Pluta, E. Bermudez, E. A. Gross, Z. Chen, K. T. Morgan, and C. Walker. (1992). p53 Mutations in formaldehyde-induced nasal squamous cell carcinomas in rats, Cancer Res., 52, 6113-6116.
62. Reitz, R. H., A. L. Menrala, R. A. Corley, J. F. Quast, M. L. Gargas, M. E. Andersen, D. A. Statts, and R. B. Conolly. (1990). Estimating the risk of liver cancer associated with human exposures to chloroform, Toxicol. Appl. Pharmacol., 105, 443-459.
63. Singer, P. C. (1993). Trihalomethanes and other by-products formed by chlorination of drinking water, in Keeping Pace with Science and Engineering: Case Studies in Environmental Regulation (M. F. Uman, ed.), National Academy Press, Washington, DC, pp. 141-164.
64. Sisk, S. C., L. J. Pluta, J. A. Bond, and L. Recio. (1994). Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene, Carcinogenesis, 15, 471-477.